Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's Disease

Stopped After the investigators and experts in the field imput it became apparent that the protocol was not reflective of clinical reality. No safety issues reported.

Conditions

• Complex Perianal Fistula
• Crohn Disease

Interventions

• DRUG: Expanded autologous adipose-derived adult stem cells (eASCs)
• DRUG: Placebo

Sponsor

Tigenix S.A.U.